Future clinical applications of genomics for acute respiratory distress syndrome.
Acute respiratory distress syndrome remains a substantial cause of morbidity and mortality in intensive care units, yet no specific pharmacotherapy has proven useful in reducing the duration of mechanical ventilation or improving survival. One factor that might hamper the development of treatment for acute respiratory distress syndrome is the heterogeneous nature of the population who present with the syndrome. In this Review, the potential of genomic approaches-genetic association, gene expression, metabolomic, proteomic, and systems biology applications-for the identification of molecular endotypes within acute respiratory distress syndrome and potentially for the prediction, diagnosis, prognosis, and treatment of this difficult disorder are discussed.
Department of Medicine Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: nuala.meyer@uphs.upenn.edu.
Nuala J
NJ
Meyer
D015316:Genetic Therapy / Q000379:methods*; D023281:Genomics / Q000379:methods*; D006801:Humans; D007362:Intensive Care Units; D012128:Respiratory Distress Syndrome / Q000628:therapy*